MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings Shares 2011-2026 | ONVO
Annual Shares Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.46 M | 762 K | 8.71 M | 6.9 M | 6.48 M | 5.77 M | 5.36 M | 4.89 M | 4.62 M | 3.98 M | 3.66 M | 61.8 M | 2.16 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.8 M | 762 K | 8.96 M |
Quarterly Shares Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.61 M | 2.6 M | 2.5 M | 1.9 M | 1.5 M | 1.5 M | 1.22 M | 10.1 M | 9.12 M | 8.72 M | 8.72 M | 8.72 M | 8.71 M | 8.71 M | 8.71 M | 8.71 M | 8.71 M | 8.7 M | 8.7 M | 8.67 M | 6.86 M | 6.86 M | 6.57 M | 131 M | 6.52 M | 130 M | 130 M | 127 M | 116 M | 116 M | 114 M | 111 M | 107 M | 106 M | 105 M | 104 M | 101 M | 101 M | 93.2 M | 92.4 M | 92.4 M | 92.4 M | 92.4 M | 83 M | 80.5 M | 80.5 M | 78.9 M | 78.2 M | 77.2 M | 72.7 M | 68.8 M | 61.8 M | 48.4 M | 44.1 M | 43.6 M | 31.6 M | 22.4 M | 12.3 M | 11.5 M | 22.4 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 131 M | 1.22 M | 52.3 M |
Shares of other stocks in the Diagnostics research industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
304 M | $ 110.28 | -2.82 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
284 M | $ 13.21 | -2.44 % | $ 3.75 B | USA |
 |
Check-Cap Ltd.
CHEK
|
5.85 M | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
|
Biodesix
BDSX
|
130 M | $ 14.31 | -2.02 % | $ 1.86 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Burning Rock Biotech Limited
BNR
|
82.1 M | $ 16.41 | -11.3 % | $ 177 M |  China |
 |
BioNano Genomics
BNGO
|
5.44 M | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Bioventus
BVS
|
66.6 M | $ 9.03 | -2.48 % | $ 602 M | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
117 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
390 M | $ 62.84 | -4.93 % | $ 24.5 B | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.54 | -5.13 % | $ 470 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
125 M | $ 84.0 | -4.65 % | $ 10.5 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
27.8 M | $ 24.0 | -2.83 % | $ 667 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
49.6 M | $ 158.89 | -3.78 % | $ 7.88 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 195.64 | -1.27 % | $ 21.7 B | USA |
 |
OpGen
OPGN
|
4.66 M | - | -16.95 % | $ 1.54 M | USA |
 |
DarioHealth Corp.
DRIO
|
3.98 M | $ 8.45 | - | $ 33.7 M | Israel |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 102.3 | -0.76 % | $ 8.44 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
80.4 M | $ 561.97 | -1.98 % | $ 45.2 B | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
159 M | $ 117.62 | -5.45 % | $ 18.7 B | USA |
 |
PerkinElmer
PKI
|
117 M | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
4.39 M | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 452.91 | -2.94 % | $ 13.1 B | USA |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 233.1 | -2.91 % | $ 25.4 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 4.38 | -5.19 % | $ 406 M | USA |
 |
ENDRA Life Sciences
NDRA
|
537 K | $ 4.26 | -7.19 % | $ 2.29 M | USA |
 |
NeoGenomics
NEO
|
128 M | $ 7.35 | -5.28 % | $ 942 M | USA |
 |
IQVIA Holdings
IQV
|
172 M | $ 164.54 | -2.87 % | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
National Research Corporation
NRC
|
22.4 M | $ 17.2 | -0.95 % | $ 385 M | USA |
 |
QIAGEN N.V.
QGEN
|
223 M | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
98.4 M | $ 184.45 | -5.96 % | $ 18.2 B | USA |
 |
OPKO Health
OPK
|
694 M | $ 1.15 | -1.79 % | $ 798 M | USA |